|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Fenofibrate]] |
| {{Fenofibrate}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Description==
| |
| | |
| Antara (fenofibrate) Capsules, is a lipid regulating agent available as capsules for oral administration. Each capsule contains 30 mg or 90 mg of micronized fenofibrate. The chemical name for fenofibrate is 2-[4-(4-chlorobenzoyl) phenoxy] 2-methyl-propanoic acid, l-methylethyl ester with the following structural formula:
| |
| {|
| |
| |[[File:Fenofibrate02.jpg|thumb|800px]]
| |
| |}
| |
| The empirical formula is C20H21O4Cl and the molecular weight is 360.83; fenofibrate is insoluble in water. The melting point is 79°-82°C. Fenofibrate is a white solid which is stable under ordinary conditions.
| |
| | |
| Inactive Ingredients: Each gelatin capsule contains hypromellose, simethicone emulsion, sodium lauryl sulphate, sugar spheres and talc. The capsule shell contains the following inactive ingredients: black iron oxide, D & C Yellow 10, potassium hydroxide, propylene glycol, gelatin, shellac, sodium lauryl sulphate, titanium dioxide. The 30 mg capsule shell contains following additional inactive ingredients: FD & C Blue 2, yellow iron oxide. The 90 mg capsule shell contains following additional inactive ingredients: FD & C Blue 1, FD & C Yellow 6.<ref>{{Cite web | last = | first = | title = ANTARA (FENOFIBRATE) CAPSULE [LUPIN PHARMA] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=12ebf783-64df-4ffa-9e84-f8fdf4d245d4 | publisher = | date = | accessdate = 12 February 2014 }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| {{Lipid modifying agents}}
| |
| {{Antigout preparations}}
| |
| | |
| [[Category:Fibrates]]
| |
| [[Category:Prodrugs]]
| |
| [[Category:Organochlorides]]
| |
| [[Category:Benzophenones]]
| |
| [[Category:Phenol ethers]]
| |
| [[Category:Carboxylate esters]]
| |